Formulation and Analytical Services
Elevate Your Drug Development, Ensure Safety and Efficacy through Expert Analytical Methods
We are dedicated to advancing pharmaceutical development through exceptional Formulation and analytical services.
We provide comprehensive formulation and analytical services for drug development, utilizing advanced facilities and an experienced team to ensure efficient product development for clinical trials and commercial production.
- Our Formulation and Analytical Services
Zenovel provides a comprehensive range of services, including the creation of injectables, solid and liquid dosage forms, and other advanced formulations, ensuring the highest standards of quality, safety, and efficacy in pharmaceutical goods, from preformulation studies to stability testing.
- Why Choose Zenovel ?
- Complete Support
Offers comprehensive support throughout the entire drug development process, from pre-formulation studies to final product testing.
- Quality and Adherence
We guarantee the highest standards of quality and regulatory compliance, ensuring your products meet all safety and efficacy guidelines.
- Experienced Team
Our team of formulation scientists is skilled in creating various dosage forms to ensure optimal drug product delivery and performance.
- Customized Solutions
Our services are customized to meet your specific project needs, providing flexible and innovative solutions.
- Quality and Adherence
We guarantee the highest standards of quality and regulatory compliance, ensuring your products meet all safety and efficacy guidelines.
- Cutting-edge Analytical Method
We offer advanced analytical laboratories utilize the latest technologies to provide precise and reliable testing results.
People Also Ask (FAQs)
Formulation and analytical services involve developing drug formulations and conducting analytical testing to ensure product quality, safety, and stability. These services support pharmaceutical companies in creating effective drug products and generating the data required for regulatory submissions.
Pharmaceutical formulation development services help determine the optimal composition and delivery method of a drug product. Proper formulation improves drug stability, bioavailability, and patient compliance, which are essential for successful pharmaceutical development.
Common services include method development, validation, impurity analysis, stability studies, and quality control testing to ensure products meet regulatory standards. Zenovel supports these activities by ensuring structured testing approaches, compliance with guidelines, and reliable data generation for high-quality and approval-ready pharmaceutical products.
Formulation and analytical services generate critical data on drug composition, stability, impurities, and analytical methods required for submissions like IND and NDA. Zenovel supports this by ensuring data is accurate, well-documented, and aligned with regulatory expectations, helping strengthen dossiers and improve approval success rates.
Zenovel provides comprehensive formulation and analytical services for drug development, including formulation design, analytical method development, stability testing, and regulatory documentation support. Their expertise helps pharmaceutical companies accelerate product development and ensure regulatory compliance.
Blogs and news
Our Latest Article
Introduction to Generic Inhalation Product Development Inhalation products pose significant challenges in generic drug development due to the complexity of formulations and device technology, making bioequivalence more difficult to establish compared to conventional oral dosage forms. Examples include Albuterol MDIs (metered dose inhalers), DPIs Dry Powder Inhalers, and nebulized therapies,
India is a significant player in the global pharmaceuticals sector, characterized by a diverse population and cost-effective infrastructure. However, its potential in clinical research is hindered by complex regulatory challenges that delay innovations and deter investment, affecting the timely market introduction of life-saving drugs. This blog discusses the major obstacles
The FDA issued 466 Form 483s to drug organizations in FY 2022, more than double the previous year, highlighting significant quality failures in the pharmaceutical sector. For startups and scale-ups seeking market approval, the excitement of innovation often conflicts with the strict requirements of current good manufacturing practices (cGMP). Although
Introduction Liposomal Amphotericin-B is a critical antifungal medication that requires careful attention during Bioequivalence (BE) studies. These studies aim to demonstrate the similarity of a generic liposomal Amphotericin B formulation to the reference drug in terms of pharmacokinetics. Zenovel, with its extensive experience in monitoring Amphotericin B studies, can play
In the pharmaceutical and biotechnology industries, obtaining regulatory approval is essential prior to introducing new drugs or biologics to the market. A pivotal aspect of this approval process is the FDA Pre-Approval Inspection (PAI), which involves a comprehensive assessment of manufacturing facilities, processes, and data integrity to ensure adherence to
Risk Based Monitoring (RBM) is a more efficient alternative to traditional clinical trials, focusing on high-risk areas through data-driven insights. It ensures patient safety, data integrity, and regulatory compliance while reducing costs and timelines. However, the success of RBM depends on the competency of monitors, who identify risks, analyze data,
